期刊
CELL REPORTS
卷 14, 期 5, 页码 1232-1245出版社
CELL PRESS
DOI: 10.1016/j.celrep.2015.12.099
关键词
-
类别
资金
- British Heart Foundation
- National Institute of Health Research Cambridge Biomedical Research Centre
- National Institute of Health Research Blood and Transplant Research Unit
- Wellcome Trust
- Raymond Scholarship
- Academy of Medical Sciences/Wellcome Trust starter grant
- Beverly Sackler Scholarship
- British Heart Foundation [FS/10/018/28193, FS/12/87/29899] Funding Source: researchfish
MHC alloantigen is recognized by two pathways: directly,'' intact on donor cells, or indirectly,'' as self-restricted allopeptide. The duration of each pathway, and its relative contribution to allograft vasculopathy, remain unclear. Using a murine model of chronic allograft rejection, we report that direct-pathway CD4 T cell alloresponses, as well as indirect-pathway responses against MHC class II alloantigen, are curtailed by rapid elimination of donor hematopoietic antigen-presenting cells. In contrast, persistent presentation of epitope resulted in continual division and less-profound contraction of the class I allopeptide-specific CD4 T cell population, with approximately 10,000-fold more cells persisting than following acute allograft rejection. This expanded population nevertheless displayed sub-optimal anamnestic responses and was unable to provide co-stimulation-independent help for generating alloantibody. Indirect-pathway CD4 T cell responses are heterogeneous. Appreciation that responses against particular alloantigens dominate at late time points will likely inform development of strategies aimed at improving transplant outcomes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据